ZB, L., DD, C., YF, J., QJ, H., L, C., FX, D., . . . SG, W. (2024). Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment. Frontiers in cellular and infection microbiology, 14, 1413589. https://doi.org/10.3389/fcimb.2024.1413589
Chicago Style (17th ed.) CitationZB, Li, et al. "Risk Factors Related to Low-level Viraemia in Chronic Hepatitis B Patients Receiving Entecavir Treatment." Frontiers in Cellular and Infection Microbiology 14 (2024): 1413589. https://doi.org/10.3389/fcimb.2024.1413589.
MLA (9th ed.) CitationZB, Li, et al. "Risk Factors Related to Low-level Viraemia in Chronic Hepatitis B Patients Receiving Entecavir Treatment." Frontiers in Cellular and Infection Microbiology, vol. 14, 2024, p. 1413589, https://doi.org/10.3389/fcimb.2024.1413589.